Cargando…
Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy
As a traditional Chinese medicine, Naoxintong capsule (NXT) has been approved by China Food and Drug Administration (CFDA), which is used for cardiocerebrovascular disease treatment. Here we found that NXT extract significantly promoted H9c2 cardiomyocyte cell autophagy involved in increased autopha...
Autores principales: | Yuan, Shuping, Jin, Jianhua, Chen, Lu, Hou, Yongzhong, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331281/ https://www.ncbi.nlm.nih.gov/pubmed/28293264 http://dx.doi.org/10.1155/2017/3801976 |
Ejemplares similares
-
Naoxintong/PPARα Signaling Inhibits H9c2 Cell Apoptosis and Autophagy in Response to Oxidative Stress
por: Xu, Huimin, et al.
Publicado: (2016) -
Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation through Activating PPARα Pathway
por: Wang, Zeng, et al.
Publicado: (2018) -
PPARα Enhances Cancer Cell Chemotherapy Sensitivity by Autophagy Induction
por: You, Mengli, et al.
Publicado: (2018) -
Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet Rats
por: Liu, Yuansheng, et al.
Publicado: (2022) -
MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARγ/NF-κB
por: Qi, Hanping, et al.
Publicado: (2019)